Dr. Kerr serves as the co-director of the Pituitary Program at the University of Colorado, Denver, where she works as part of a multi-disciplinary team to provide comprehensive care to patients with pituitary disorders. Her basic science research interests are in the areas of pituitary tumor pathogenesis and thyroid stimulating hormone beta subunit (TSH-beta) gene regulation. Her clinical research interests include novel therapeutics for patients with Cushing's Disease and Acromegaly.
Dr. Kerr is an integraul member of the Thryoid Cancer Tumor Program, working in a multi-disciplinary group of physicians, surgeons, radiologists, oncologists and radiation oncologist. Dr Kerr has special expertise in papillary and medullary thyroid cancers. Specific areas of interest include nuclear hormone receptors (RXR, TR, PPAR) and kinase signaling pathways as therapeutic targets in thyroid cancer molecular markers in thyroid neoplasms.